Researcher.Life Logo

Nuclear Medicine and Biology : Impact Factor & More

eISSN: 1872-9614pISSN: 0969-8051

Key Metrics

CiteScore
4.2
H-Index
96
Impact Factor
< 5
SJR
Q2Cancer Research
SNIP
0.69
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Nuclear Medicine and Biology

Nuclear Medicine and Biology Journal Specifications

Overview
Publisher ELSEVIER SCIENCE INC
Language Multi-Language
Frequency Bi-monthly
General Details
LanguageMulti-Language
FrequencyBi-monthly
Publication Start Year1993
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Nuclear Medicine and Biology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Nuclear Medicine and Biology

Development of glycoside-based nuclear medicine imaging agents for the sodium-glucose co-transporters in cancer cells.
  • 1 Jan 2026
  • Nuclear medicine and biology
PET imaging of [64Cu]copper(II) chloride and tetrathiomolybdate administration in animal models of triple-negative breast cancer.
  • 1 Jan 2026
  • Nuclear medicine and biology
Scandium-47 as a radionuclide precursor: Feasibility of production in a 47Ca/47Sc generator-like system.
  • 1 Jan 2026
  • Nuclear medicine and biology
Matched pair suitability of 89Zr and 177Lu-labeled L804-LLP2A theranostics for targeting VLA-4 in melanoma.
  • 1 Dec 2025
  • Nuclear medicine and biology
Expression of concern “cross sections of the 226Ra(p,xn) reactions relevant for 225Ac production“
  • 1 Dec 2025
  • Nuclear Medicine and Biology
Integrating [11C]methylreboxetine PET and MRI to map in vivo norepinephrine transporter distribution: A proof-of-concept study of noradrenergic vulnerability in neurodegeneration.
  • 17 Nov 2025
  • Nuclear medicine and biology
Development of glycoside-based nuclear medicine imaging agents for the sodium-glucose co-transporters in cancer cells.
  • 1 Jan 2026
  • Nuclear medicine and biology
PET imaging of [64Cu]copper(II) chloride and tetrathiomolybdate administration in animal models of triple-negative breast cancer.
  • 1 Jan 2026
  • Nuclear medicine and biology
Scandium-47 as a radionuclide precursor: Feasibility of production in a 47Ca/47Sc generator-like system.
  • 1 Jan 2026
  • Nuclear medicine and biology
Matched pair suitability of 89Zr and 177Lu-labeled L804-LLP2A theranostics for targeting VLA-4 in melanoma.
  • 1 Dec 2025
  • Nuclear medicine and biology
Expression of concern “cross sections of the 226Ra(p,xn) reactions relevant for 225Ac production“
  • 1 Dec 2025
  • Nuclear Medicine and Biology
Integrating [11C]methylreboxetine PET and MRI to map in vivo norepinephrine transporter distribution: A proof-of-concept study of noradrenergic vulnerability in neurodegeneration.
  • 17 Nov 2025
  • Nuclear medicine and biology

FAQs on Nuclear Medicine and Biology